Zurcher Kantonalbank (Zurich Cantonalbank) - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$63,212
+126.8%
3,393
+216.2%
0.00%
Q2 2023$27,877
-9.5%
1,0730.0%0.00%
Q1 2023$30,817
-3.0%
1,0730.0%0.00%
Q4 2022$31,761
+22.2%
1,0730.0%0.00%
Q3 2022$26,000
+8.3%
1,0730.0%0.00%
Q2 2022$24,000
-11.1%
1,0730.0%0.00%
Q1 2022$27,000
-28.9%
1,0730.0%0.00%
Q4 2021$38,000
-17.4%
1,0730.0%0.00%
Q3 2021$46,0000.0%1,0730.0%0.00%
Q2 2021$46,000
+4.5%
1,0730.0%0.00%
Q1 2021$44,000
-10.2%
1,0730.0%0.00%
Q4 2020$49,000
-29.0%
1,073
-44.7%
0.00%
Q3 2020$69,000
-5.5%
1,9390.0%0.00%
-100.0%
Q2 2020$73,000
+160.7%
1,939
+102.6%
0.00%
Q1 2020$28,000
-44.0%
9570.0%0.00%
Q4 2019$50,000
-5.7%
9570.0%0.00%
Q3 2019$53,000
+35.9%
9570.0%0.00%
Q2 2019$39,000
+34.5%
9570.0%0.00%
Q1 2019$29,000
-9.4%
9570.0%0.00%
Q4 2018$32,000
-20.0%
9570.0%0.00%
Q3 2018$40,000
+29.0%
9570.0%0.00%
Q2 2018$31,000
-35.4%
9570.0%0.00%
Q1 2018$48,000
-7.7%
9570.0%0.00%
Q4 2017$52,000
+57.6%
957
+66.7%
0.00%
Q3 2017$33,000
+17.9%
5740.0%0.00%
Q2 2017$28,000
+12.0%
5740.0%0.00%
Q1 2017$25,000
-10.7%
5740.0%0.00%
Q4 2016$28,000
+3.7%
5740.0%0.00%
Q3 2016$27,000
+12.5%
574
+28.1%
0.00%
Q2 2016$24,000
+20.0%
4480.0%0.00%
Q1 2016$20,000
+17.6%
4480.0%0.00%
Q4 2015$17,000
+183.3%
448
+128.6%
0.00%
Q3 2015$6,0000.0%1960.0%0.00%
Q2 2015$6,000
-25.0%
1960.0%0.00%
Q1 2015$8,0001960.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders